https://www.selleckchem.com/products/lxh254.html
9 vs. 75.0%, = 0.39. The recurrence rates in patients with LSIL treated with FUS therapy or cryotherapy showed no significant differences at the 6-12-month follow-up (1.0 vs. 6.0%, = 0.163). Furthermore, there was no recurrence in patients with HSIL, either in the FUS or cryotherapy group. FUS therapy and cryotherapy resulted in similar HPV clearance at the 3-6-month follow-up (77.1 vs. 64.8%, = 0.057). No statistically significant differences were observed in the complication rates between the two groups (3.5 vs. 1.9%, = 0.717). T
Like
Comment
Share
